Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation.

Krista L. Lentine, Mark A. Schnitzler, Kevin C. Abbott, Leiming Li, Huiling Xiao, Thomas E. Burroughs, Steven K. Takemoto, Lisa M. Willoughby, Jeffrey A. Gavard, Daniel Brennan

Research output: Contribution to journalArticle

Abstract

The risk for and predictors of atrial fibrillation (AF) after kidney transplantation are not well described. Registry data that were collected by the United States Renal Data System were used to investigate retrospectively new-onset AF among adult first renal allograft recipients and transplant candidates who received a transplant or were wait-listed in 1995 to 2001 with Medicare as the primary payer. AF events were ascertained from billing records, and participants were followed until loss of Medicare coverage or December 31, 2001. Cox hazards analysis was used to identify independent correlates of posttransplantation AF (adjusted hazard ratio [AHR]; 95% confidence interval [CI]) and to examine AF as an outcomes predictor. Among 31,136 eligible transplant recipients, the cumulative incidence of new-onset AF was 3.6% (95% CI 3.4 to 3.8%) and 7.3% (95% CI 7.0 to 7.6%) at 12 and 36 mo and declined below the demographics-adjusted cumulative incidence on the waiting list by approximately 17 mo. Risk factors for posttransplantation AF included older recipient age, male gender, white race, renal failure from hypertension, and coronary artery disease. Extended pretransplantation dialysis duration, posttransplantation diabetes, and graft failure were identified as potentially modifiable correlates of AF. In separate analyses, AF independently predicted death (AHR 3.2; 95% CI 2.9 to 3.6) and death-censored graft loss (AHR 1.9; 95% CI 1.6 to 2.3). As the population of renal transplant recipients grows older, the incidence and prevalence of AF among these patients will likely increase. Appropriate risk stratification may identify transplant recipients who are in need of close monitoring for and management of this adverse cardiovascular event.

Original languageEnglish (US)
Pages (from-to)288-296
Number of pages9
JournalClinical journal of the American Society of Nephrology : CJASN
Volume1
Issue number2
DOIs
StatePublished - Mar 1 2006
Externally publishedYes

Fingerprint

Kidney Transplantation
Atrial Fibrillation
Incidence
Confidence Intervals
Medicare
Transplants
Kidney
Renal Hypertension
Waiting Lists
Information Systems
Renal Insufficiency
Allografts
Registries
Coronary Artery Disease
Dialysis
Demography
Transplant Recipients

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. / Lentine, Krista L.; Schnitzler, Mark A.; Abbott, Kevin C.; Li, Leiming; Xiao, Huiling; Burroughs, Thomas E.; Takemoto, Steven K.; Willoughby, Lisa M.; Gavard, Jeffrey A.; Brennan, Daniel.

In: Clinical journal of the American Society of Nephrology : CJASN, Vol. 1, No. 2, 01.03.2006, p. 288-296.

Research output: Contribution to journalArticle

Lentine, KL, Schnitzler, MA, Abbott, KC, Li, L, Xiao, H, Burroughs, TE, Takemoto, SK, Willoughby, LM, Gavard, JA & Brennan, D 2006, 'Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation.', Clinical journal of the American Society of Nephrology : CJASN, vol. 1, no. 2, pp. 288-296. https://doi.org/10.2215/CJN.00920805
Lentine, Krista L. ; Schnitzler, Mark A. ; Abbott, Kevin C. ; Li, Leiming ; Xiao, Huiling ; Burroughs, Thomas E. ; Takemoto, Steven K. ; Willoughby, Lisa M. ; Gavard, Jeffrey A. ; Brennan, Daniel. / Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. In: Clinical journal of the American Society of Nephrology : CJASN. 2006 ; Vol. 1, No. 2. pp. 288-296.
@article{4fe8f9010d2244af887536ba9f75223b,
title = "Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation.",
abstract = "The risk for and predictors of atrial fibrillation (AF) after kidney transplantation are not well described. Registry data that were collected by the United States Renal Data System were used to investigate retrospectively new-onset AF among adult first renal allograft recipients and transplant candidates who received a transplant or were wait-listed in 1995 to 2001 with Medicare as the primary payer. AF events were ascertained from billing records, and participants were followed until loss of Medicare coverage or December 31, 2001. Cox hazards analysis was used to identify independent correlates of posttransplantation AF (adjusted hazard ratio [AHR]; 95{\%} confidence interval [CI]) and to examine AF as an outcomes predictor. Among 31,136 eligible transplant recipients, the cumulative incidence of new-onset AF was 3.6{\%} (95{\%} CI 3.4 to 3.8{\%}) and 7.3{\%} (95{\%} CI 7.0 to 7.6{\%}) at 12 and 36 mo and declined below the demographics-adjusted cumulative incidence on the waiting list by approximately 17 mo. Risk factors for posttransplantation AF included older recipient age, male gender, white race, renal failure from hypertension, and coronary artery disease. Extended pretransplantation dialysis duration, posttransplantation diabetes, and graft failure were identified as potentially modifiable correlates of AF. In separate analyses, AF independently predicted death (AHR 3.2; 95{\%} CI 2.9 to 3.6) and death-censored graft loss (AHR 1.9; 95{\%} CI 1.6 to 2.3). As the population of renal transplant recipients grows older, the incidence and prevalence of AF among these patients will likely increase. Appropriate risk stratification may identify transplant recipients who are in need of close monitoring for and management of this adverse cardiovascular event.",
author = "Lentine, {Krista L.} and Schnitzler, {Mark A.} and Abbott, {Kevin C.} and Leiming Li and Huiling Xiao and Burroughs, {Thomas E.} and Takemoto, {Steven K.} and Willoughby, {Lisa M.} and Gavard, {Jeffrey A.} and Daniel Brennan",
year = "2006",
month = "3",
day = "1",
doi = "10.2215/CJN.00920805",
language = "English (US)",
volume = "1",
pages = "288--296",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "2",

}

TY - JOUR

T1 - Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation.

AU - Lentine, Krista L.

AU - Schnitzler, Mark A.

AU - Abbott, Kevin C.

AU - Li, Leiming

AU - Xiao, Huiling

AU - Burroughs, Thomas E.

AU - Takemoto, Steven K.

AU - Willoughby, Lisa M.

AU - Gavard, Jeffrey A.

AU - Brennan, Daniel

PY - 2006/3/1

Y1 - 2006/3/1

N2 - The risk for and predictors of atrial fibrillation (AF) after kidney transplantation are not well described. Registry data that were collected by the United States Renal Data System were used to investigate retrospectively new-onset AF among adult first renal allograft recipients and transplant candidates who received a transplant or were wait-listed in 1995 to 2001 with Medicare as the primary payer. AF events were ascertained from billing records, and participants were followed until loss of Medicare coverage or December 31, 2001. Cox hazards analysis was used to identify independent correlates of posttransplantation AF (adjusted hazard ratio [AHR]; 95% confidence interval [CI]) and to examine AF as an outcomes predictor. Among 31,136 eligible transplant recipients, the cumulative incidence of new-onset AF was 3.6% (95% CI 3.4 to 3.8%) and 7.3% (95% CI 7.0 to 7.6%) at 12 and 36 mo and declined below the demographics-adjusted cumulative incidence on the waiting list by approximately 17 mo. Risk factors for posttransplantation AF included older recipient age, male gender, white race, renal failure from hypertension, and coronary artery disease. Extended pretransplantation dialysis duration, posttransplantation diabetes, and graft failure were identified as potentially modifiable correlates of AF. In separate analyses, AF independently predicted death (AHR 3.2; 95% CI 2.9 to 3.6) and death-censored graft loss (AHR 1.9; 95% CI 1.6 to 2.3). As the population of renal transplant recipients grows older, the incidence and prevalence of AF among these patients will likely increase. Appropriate risk stratification may identify transplant recipients who are in need of close monitoring for and management of this adverse cardiovascular event.

AB - The risk for and predictors of atrial fibrillation (AF) after kidney transplantation are not well described. Registry data that were collected by the United States Renal Data System were used to investigate retrospectively new-onset AF among adult first renal allograft recipients and transplant candidates who received a transplant or were wait-listed in 1995 to 2001 with Medicare as the primary payer. AF events were ascertained from billing records, and participants were followed until loss of Medicare coverage or December 31, 2001. Cox hazards analysis was used to identify independent correlates of posttransplantation AF (adjusted hazard ratio [AHR]; 95% confidence interval [CI]) and to examine AF as an outcomes predictor. Among 31,136 eligible transplant recipients, the cumulative incidence of new-onset AF was 3.6% (95% CI 3.4 to 3.8%) and 7.3% (95% CI 7.0 to 7.6%) at 12 and 36 mo and declined below the demographics-adjusted cumulative incidence on the waiting list by approximately 17 mo. Risk factors for posttransplantation AF included older recipient age, male gender, white race, renal failure from hypertension, and coronary artery disease. Extended pretransplantation dialysis duration, posttransplantation diabetes, and graft failure were identified as potentially modifiable correlates of AF. In separate analyses, AF independently predicted death (AHR 3.2; 95% CI 2.9 to 3.6) and death-censored graft loss (AHR 1.9; 95% CI 1.6 to 2.3). As the population of renal transplant recipients grows older, the incidence and prevalence of AF among these patients will likely increase. Appropriate risk stratification may identify transplant recipients who are in need of close monitoring for and management of this adverse cardiovascular event.

UR - http://www.scopus.com/inward/record.url?scp=34548443681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548443681&partnerID=8YFLogxK

U2 - 10.2215/CJN.00920805

DO - 10.2215/CJN.00920805

M3 - Article

C2 - 17699219

AN - SCOPUS:34548443681

VL - 1

SP - 288

EP - 296

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 2

ER -